Cargando…
Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives
Developing medicines for hemodynamic disorders that are characteristic of cirrhosis of the liver is a relevant problem in modern hepatology. The increase in hepatic vascular resistance to portal blood flow and subsequent hyperdynamic circulation underlie portal hypertension (PH) and promote its prog...
Autores principales: | Garbuzenko, Dmitry Victorovich, Arefyev, Nikolay Olegovich, Kazachkov, Evgeniy Leonidovich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127663/ https://www.ncbi.nlm.nih.gov/pubmed/30197479 http://dx.doi.org/10.3748/wjg.v24.i33.3738 |
Ejemplares similares
-
Restructuring of the vascular bed in response to hemodynamic disturbances in portal hypertension
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2016) -
Current approaches to the management of patients with cirrhotic ascites
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2019) -
Hepatic hydrothorax: An update and review of the literature
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2017) -
Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2023) -
Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2022)